Read by QxMD icon Read


shared collection
2 papers 0 to 25 followers
Peter Bader, Hermann Kreyenberg, Arend von Stackelberg, Cornelia Eckert, Emilia Salzmann-Manrique, Roland Meisel, Ulrike Poetschger, Daniel Stachel, Martin Schrappe, Julia Alten, Andre Schrauder, Ansgar Schulz, Peter Lang, Ingo Müller, Michael H Albert, Andre M Willasch, Thomas E Klingebiel, Christina Peters
PURPOSE: To elucidate the impact of minimal residual disease (MRD) after allogeneic transplantation, the Acute Lymphoblastic Leukemia Berlin-Frankfurt-Münster Stem Cell Transplantation Group (ALL-BFM-SCT) conducted a prospective clinical trial. PATIENTS AND METHODS: In the ALL-BFM-SCT 2003 trial, MRD was assessed in the bone marrow at days +30, +60, +90, +180, and +365 after transplantation in 113 patients with relapsed disease. Standardized quantification of MRD was performed according to the guidelines of the Euro-MRD Group...
April 10, 2015: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
Albert Oriol
No abstract text is available yet for this article.
2015: Acta Haematologica
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"